Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance [Yahoo! Finance]
Harrow Health, Inc. (HROW)
Last harrow health, inc. earnings: 11/13 04:21 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Harrow, Inc. Fourth Quarter, Full-Year 2025 and Selected Highlights: Record quarterly revenue of $89.1 million, a 33% increase over $66.8 million recorded in the prior-year period Full-Year revenue of $272.3 million, a 36% increase over $199.6 million recorded in 2024 GAAP net income of $6.6 million in Q4 2025, and net loss $5.1 million for 2025 Adjusted EBITDA of $24.2 million in Q4 2025, and $61.9 million for 2025 Generated $43.9 million of operating cash flow in 2025, versus $(22.2) million used in operations in 2024 Cash and cash equivalents of $72.9 million as of December 31, 2025 Full-year 2026 revenue guidance of $350 million to $365 million, including $133 million to $153 million in the first half of 2026 and $203 million to $226 million in the second half of 2026 Full-year 2026 Adjusted EBITDA guidance of $80 million to $100 million A Media Snippet accompanying this announcement is available by clicking on this link. NASHVILLE, Tenn., March 02, 2026 (GL
Show less
Read more
Impact Snapshot
Event Time:
HROW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HROW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HROW alerts
High impacting Harrow Health, Inc. news events
Weekly update
A roundup of the hottest topics
HROW
News
- Harrow (HROW) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- Harrow (HROW) had its price target lowered by Cantor Fitzgerald from $94.00 to $91.00. They now have an "overweight" rating on the stock.MarketBeat
- Harrow (HROW) had its price target raised by HC Wainwright from $69.00 to $70.00. They now have a "buy" rating on the stock.MarketBeat
- Harrow to Present at Leerink Partner's 2026 Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Harrow to Present at Leerink Partner’s 2026 Global Healthcare ConferenceGlobeNewswire
HROW
Earnings
- 3/2/26 - Miss
HROW
Sec Filings
- 3/5/26 - Form 4
- 3/3/26 - Form 4
- 3/2/26 - Form 10-K
- HROW's page on the SEC website